ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent manner

被引:0
|
作者
Fat-Moon Suk
Chi-Ching Chang
Ren-Jye Lin
Shyr-Yi Lin
Shih-Chen Liu
Chia-Feng Jau
Yu-Chih Liang
机构
[1] Taipei Medical University,Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital
[2] School of Medicine,Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine
[3] College of Medicine,Division of Rheumatology, Immunology and Allergy
[4] Taipei Medical University,School of Medical Laboratory Science and Biotechnology
[5] Taipei Medical University Hospital,Department of Primary Care Medicine
[6] College of Medical Science and Technology,Department of General Medicine, School of Medicine
[7] Taipei Medical University,Traditional Herbal Medicine Research Center
[8] Taipei Medical University Hospital,Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology
[9] College of Medicine,undefined
[10] Taipei Medical University,undefined
[11] Taipei Medical University Hospital,undefined
[12] Taipei Medical University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
ZFP36 family members include ZFP36, ZFP36L1, and ZFP36L2, which belong to CCCH-type zinc finger proteins with two tandem zinc finger (TZF) regions. Whether ZFP36L1 and ZFP36L2 have antiproliferative activities similar to that of ZFP36 is unclear. In this study, when ZFP36L1 or ZFP36L2 was overexpressed in T-REx-293 cells, cell proliferation was dramatically inhibited and the cell cycle was arrested at the G1 phase. The levels of cell-cycle-related proteins, including cyclin B, cyclin D, cyclin A, and p21, decreased; however, p53 increased in ZFP36L1-or ZFP36L2-overexpressing T-REx-293 cells. Forced expression of ZFP36L1 or ZFP36L2 also inhibited cell proliferation and cyclin D gene expression in three human colorectal cancer cell lines: HCT116 p53+/+, HCT116 p53−/−, and SW620 (mutated p53) cells. However, it increased p53 and p21 expression only in HCT116 p53+/+ cells. Knockdown of ZFP36L1 or ZFP36L2 increased cell proliferation and cyclin D expression; furthermore, the mutation of the TZF of ZFP36L1 or ZFP36L2 caused them to lose their antiproliferative ability, to the extent that they could not inhibit cyclin D expression in these three cell lines. The results indicated that ZFP36L1 and ZFP36L2 play a negative role in cell proliferation; the underlying mechanisms might be mediated through a cyclin D-dependent and p53-independent pathway.
引用
收藏
相关论文
共 50 条
  • [21] ZFP36L1 and ZFP36L2 reduce cyclin D1 expression by decreasing expression of E2F1 and long 3'UTR isoform of CCND1 transcripts
    Chan, Tze-Sian
    Lee, Kun-Lin
    Hung, Ching-Sheng
    Chiang, Hsin-Pei
    Chung, Chia-Chen
    Liang, Yu-Chih
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025, 480 (03) : 1685 - 1699
  • [22] Erratum: Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia
    Daniel J Hodson
    Michelle L Janas
    Alison Galloway
    Sarah E Bell
    Simon Andrews
    Cheuk M Li
    Richard Pannell
    Christian W Siebel
    H Robson MacDonald
    Kim De Keersmaecker
    Adolfo A Ferrando
    Gerald Grutz
    Martin Turner
    Nature Immunology, 2010, 11 : 969 - 969
  • [23] Analyzing biological function of truncated ZFP36L1 variants and confirmation of CSF-1 as a ZFP36L1 target
    Kasten, Anne
    Kaehler, Meike
    Cascorbi, Ingolf
    Nagel, Inga
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 1175 - 1176
  • [24] ZFP36L2 Role in Thyroid Functionality
    Albano, Francesco
    Tucci, Valeria
    Blackshear, Perry J.
    Reale, Carla
    Roberto, Luca
    Russo, Filomena
    Marotta, Pina
    Porreca, Immacolata
    Colella, Marco
    Mallardo, Massimo
    de Felice, Mario
    Ambrosino, Concetta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [25] Evolving drug resistance in chronic myeloid leukemia - Role of RNA-binding proteins ZFP36L1 and ZFP36L2 on imatinib-susceptibility
    Kaehler, M.
    Vater, I.
    Cascorbi, I.
    Nagel, I.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S50 - S50
  • [26] Liver-Specific Deletion of RNA-Binding Proteins ZFP36L1 and ZFP36L2 Mitigates Carbon Tetrachloride-Induced Hepatotoxicity
    Kumar, Rahul
    Patial, Sonika
    Saini, Yogesh
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2024, 43 (01) : 78 - 78
  • [27] The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic β-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression
    Vogel, Katharina U.
    Bell, Lewis S.
    Galloway, Alison
    Ahlfors, Helena
    Turner, Martin
    JOURNAL OF IMMUNOLOGY, 2016, 197 (07): : 2673 - 2685
  • [28] Recirculating Regulatory T Cells Mediate Thymic Regeneration in a ZFP36L1 and Amphiregulin Dependent Manner
    Lemarquis, Andri Leo L.
    Kousa, Anastasia
    Argyropoulos, Kimon V.
    Jahn, Lorenz
    Gipson, Brianna
    Serrano-Marin, Lucia
    Andrlova, Hana
    Tsai, Jennifer
    Dudakov, Jarrod A.
    DeWolf, Susan
    van den Brink, Marcel R. M.
    BLOOD, 2023, 142
  • [29] Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia (vol 11, pg 717, 2010)
    Hodson, Daniel J.
    Janas, Michelle L.
    Galloway, Alison
    Bell, Sarah E.
    Andrews, Simon
    Li, Cheuk M.
    Pannell, Richard
    Siebel, Christian W.
    MacDonald, H. Robson
    De Keersmaecker, Kim
    Ferrando, Adolfo A.
    Grutz, Gerald
    Turner, Martin
    NATURE IMMUNOLOGY, 2010, 11 (10) : 969 - 969
  • [30] Novel phosphorelay-dependent control of ZFP36L1 protein during the cell cycle
    Kondo, Makoto
    Noguchi, Aya
    Matsuura, Yuki
    Shimada, Masumi
    Yokota, Naoto
    Kawahara, Hiroyuki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 501 (02) : 387 - 393